Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K Breuhahn1, T Longerich, P Schirmacher
1Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
Abstract:
Dysregulation of pleiotropic growth factors, receptors and their downstream signaling pathway components represent a central protumorigenic principle in human hepatocarcinogenesis. Especially the Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/beta-catenin/FZD), Transforming Growth Factor alpha/Epidermal Growth Factor receptor (TGFalpha/EGFR) and Transforming Growth Factor beta (TGFbeta/TbetaR) pathways contribute to proliferation, antiapoptosis and invasive behavior of tumor cells. This review focuses on the relevant alterations in these pathways identified in human human hepatocellular carcinomas (HCCs). Resultant functional effects are modulated by multiple cross-talks between the different signaling pathways and additional tumor-relevant factors, such as cyclooxygenase-2 and p53. Several specific strategies are currently under development such as receptor kinase inhibitors, neutralizing antibodies and antagonistic proteins, which may improve the systemic treatment of human HCCs.
Insights
Dysregulated growth factor pathways, including IGF-1, HGF, Wnt, and TGF, drive liver cancer (HCC) progression. Targeting these pathways offers new therapeutic strategies for hepatocellular carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Pleiotropic growth factors and their signaling pathways are crucial in human hepatocarcinogenesis.
- Key pathways involved include Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/beta-catenin/FZD), Transforming Growth Factor alpha/Epidermal Growth Factor receptor (TGFalpha/EGFR), and Transforming Growth Factor beta (TGFbeta/TbetaR).
Purpose of the Study:
- To review critical alterations in major signaling pathways in human hepatocellular carcinomas (HCCs).
- To highlight the contribution of these pathways to tumor cell proliferation, survival, and invasion.
Main Methods:
- Literature review focusing on signaling pathway alterations in human HCC.
- Analysis of cross-talk between different signaling pathways and other tumor factors like cyclooxygenase-2 and p53.
Main Results:
- Dysregulation of IGF/IGF-1R, HGF/MET, Wnt, TGFalpha/EGFR, and TGFbeta/TbetaR pathways are central to HCC development.
- Functional effects are modulated by pathway cross-talks and factors such as cyclooxygenase-2 and p53.
Conclusions:
- Understanding these pathway alterations is key to developing targeted therapies for HCC.
- Strategies like receptor kinase inhibitors and neutralizing antibodies are under development for improved systemic treatment of HCC.
Related Concept Videos
Factors Influencing Microbial Growth: Osmolarity
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: pH
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Transcription Factors
Population Growth

